[The therapy of supraventricular abnormal rhythms with Orciprenalin in the so-called transition phase after cardioversion].
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000517:prevention & control; D004554:Electric Countershock; D004562:Electrocardiography; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use; D012118:Resorcinols / Q000627:therapeutic use*
D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol
Die Therpie supraventrikulärer Ersatzrhythmen in der sogenannten uebergangsphase nach Kardioversion mit Orciprenalin.